about
Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection.Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer.Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma.Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular CarcinomaComparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinomaGUCY2C molecular staging personalizes colorectal cancer patient managementPrognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors.Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis.Neutrophils in the Tumor Microenvironment.Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort studyThe Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy.Adult nutrition assessment tutorial.Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma.Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer.Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.Optimizing cancer care: is the future bright?Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis.
P2860
Q33613637-21A5379D-5A2C-4747-BDF1-D4A64351C1D3Q33621633-206F2EBB-9985-46F2-99E3-8FBEF2981AF2Q34281919-A4B8D5A2-28CC-4D6F-BF9D-EA855EB48BE6Q35766555-DE312ABB-5635-48AE-800A-78218AFC69F0Q35863154-56E452D5-6925-4C02-9C0D-45EE6186B850Q35927872-A259582F-407A-4EB9-8928-8E0298271A38Q36166771-4FB5E784-010D-4B5C-9F95-5B1CB59058C9Q36186701-43538C66-C6B3-4211-8904-3E15B5B7E75DQ36194925-A8EFB877-4598-490A-A910-E8DCC8B9A0B7Q36299107-A14E569F-2C61-4AAE-823D-0480CEDCD3D7Q36336227-A56BF9EE-61A2-493B-A835-E7439E4F3A8EQ36412149-34F35CFD-90EA-4CCD-89D2-4AE6276F2334Q36636814-F2729C6A-E431-46F7-BAEB-A0FE718452C7Q37493557-3967B178-F977-4DE7-967E-E33548E16AEDQ38678088-3DBE1DC3-2ACC-4F11-8EA6-68EDA4E6E0F0Q38763938-6C831FDC-B3FB-485E-BF78-E3116C1ABBC0Q42376782-25F56AFB-68F1-4EA9-B448-E2FC4447F75FQ42723562-90A6C867-97FA-44A1-A651-399FCEE72151Q43716179-4689C44B-74DB-4614-88B4-6E95660A654CQ45226908-073AA1DB-7E87-4DBD-BD2D-600D05E9F4CDQ48351441-33324127-F949-4126-B5FA-3ABE0BD303B7Q51149399-BD506975-D4ED-4E32-8E21-375250BAA9A8Q51684485-6DBCEB52-AB58-4B12-A854-893D70F1A911Q55029432-8DFE2A25-E4B8-44F9-87CD-A89494440FA9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of inflammatory markers to guide cancer treatment.
@en
Use of inflammatory markers to guide cancer treatment.
@nl
type
label
Use of inflammatory markers to guide cancer treatment.
@en
Use of inflammatory markers to guide cancer treatment.
@nl
prefLabel
Use of inflammatory markers to guide cancer treatment.
@en
Use of inflammatory markers to guide cancer treatment.
@nl
P2093
P2860
P356
P1476
Use of inflammatory markers to guide cancer treatment
@en
P2093
S J Clarke
P2860
P304
P356
10.1038/CLPT.2011.122
P407
P577
2011-07-20T00:00:00Z